• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在识别糖耐量异常风险方面,年龄、体重指数和种族不如随机血糖重要:葡萄糖耐量受损筛查研究(SIGT 5)。

Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5).

作者信息

Ziemer David C, Kolm Paul, Weintraub William S, Vaccarino Viola, Rhee Mary K, Caudle Jane M, Irving Jade M, Koch David D, Narayan K M Venkat, Phillips Lawrence S

机构信息

Division of Endocrinology and Metabolism, Emory University, Atlanta, Georgia 30322, USA.

出版信息

Diabetes Care. 2008 May;31(5):884-6. doi: 10.2337/dc07-2282. Epub 2008 Feb 29.

DOI:10.2337/dc07-2282
PMID:18310308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3685424/
Abstract

OBJECTIVE

Age, BMI, and race/ethnicity are used in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and American Diabetes Association (ADA) guidelines to prompt screening for pre-diabetes and diabetes, but cutoffs have not been evaluated rigorously.

RESEARCH DESIGN AND METHODS

Random plasma glucose (RPG) was measured and 75-g oral glucose tolerance tests were performed in 1,139 individuals without known diabetes. Screening performance was assessed by logistic regression and area under the receiver operating characteristic curve (AROC).

RESULTS

NIDDK/ADA indicators age >45 years and BMI >25 kg/m(2) provided significant detection of both diabetes and dysglycemia (both AROCs 0.63), but screening was better with continuous-variable models of age, BMI, and race and better still with models of age, BMI, race, sex, and family history (AROC 0.78 and 0.72). However, screening was even better with RPG alone (AROCs 0.81 and 0.72). RPG >125 mg/dl could be used to prompt further evaluation with an OGTT.

CONCLUSIONS

Use of age, BMI, and race/ethnicity in guidelines for screening to detect diabetes and pre-diabetes may be less important than evaluation of RPG. RPG should be investigated further as a convenient, inexpensive screen with good predictive utility.

摘要

目的

美国国立糖尿病、消化和肾脏疾病研究所(NIDDK)及美国糖尿病协会(ADA)的指南中使用年龄、体重指数(BMI)和种族/族裔来促使对糖尿病前期和糖尿病进行筛查,但相关临界值尚未得到严格评估。

研究设计与方法

对1139名无糖尿病史的个体测量随机血糖(RPG)并进行75克口服葡萄糖耐量试验。通过逻辑回归和受试者操作特征曲线下面积(AROC)评估筛查性能。

结果

NIDDK/ADA指标年龄>45岁和BMI>25kg/m²对糖尿病和血糖异常均有显著检出率(AROC均为0.63),但年龄、BMI和种族的连续变量模型筛查效果更好,年龄、BMI、种族、性别和家族史模型的筛查效果更佳(AROC分别为0.78和0.72)。然而,单独使用RPG筛查效果更好(AROC分别为0.81和0.72)。RPG>125mg/dl可用于促使进行口服葡萄糖耐量试验(OGTT)进一步评估。

结论

在筛查糖尿病和糖尿病前期的指南中使用年龄、BMI和种族/族裔可能不如评估RPG重要。RPG作为一种方便、廉价且具有良好预测效用的筛查方法应进一步研究。

相似文献

1
Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5).在识别糖耐量异常风险方面,年龄、体重指数和种族不如随机血糖重要:葡萄糖耐量受损筛查研究(SIGT 5)。
Diabetes Care. 2008 May;31(5):884-6. doi: 10.2337/dc07-2282. Epub 2008 Feb 29.
2
The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance.“代谢综合征”在筛查糖耐量异常方面不如随机血糖有用。
Prim Care Diabetes. 2008 Sep;2(3):147-53. doi: 10.1016/j.pcd.2008.04.005. Epub 2008 Jun 11.
3
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.偶然筛查糖耐量异常时的随机血浆葡萄糖:糖耐量受损筛查研究2
J Gen Intern Med. 2008 May;23(5):528-35. doi: 10.1007/s11606-008-0524-1. Epub 2008 Mar 12.
4
Impact of the American Diabetes Association diagnosis criteria on high-risk Spanish population. IGT Research Group. Impaired glucose tolerance.美国糖尿病协会诊断标准对西班牙高危人群的影响。糖耐量受损研究组。糖耐量受损
Diabetes Res Clin Pract. 1999 Oct;46(1):75-81. doi: 10.1016/s0168-8227(99)00066-2.
5
Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.糖尿病筛查——对空腹血糖受损个体采用两步法可提高对有并发症风险者的检测率。
Diabet Med. 2000 Nov;17(11):771-5. doi: 10.1046/j.1464-5491.2000.00382.x.
6
Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.糖化血红蛋白(HbA1c)与口服葡萄糖耐量试验(OGTT)作为诊断高危泰国患者血糖异常状态筛查工具的性能比较。
BMC Endocr Disord. 2019 Feb 15;19(1):23. doi: 10.1186/s12902-019-0339-6.
7
Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.联合使用空腹血糖浓度和糖化血红蛋白(HbA1c)或果糖胺可预测高危人群患糖尿病的可能性。
Diabetes Care. 1998 Aug;21(8):1221-5. doi: 10.2337/diacare.21.8.1221.
8
Performance of recommended screening tests for undiagnosed diabetes and dysglycemia.未诊断糖尿病和血糖异常的推荐筛查试验的性能。
Diabetes Care. 2001 Nov;24(11):1899-903. doi: 10.2337/diacare.24.11.1899.
9
Diagnosis of diabetes mellitus and intermediate glucose abnormalities in obese patients based on ADA (1997) and WHO (1985) criteria.基于美国糖尿病协会(1997年)和世界卫生组织(1985年)的标准对肥胖患者的糖尿病及中间型血糖异常进行诊断。
Diabet Med. 2002 Apr;19(4):292-9. doi: 10.1046/j.1464-5491.2002.00647.x.
10
[Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].[持续葡萄糖监测在囊性纤维化患者糖尿病筛查中的价值]
Arch Pediatr. 2009 Dec;16(12):1540-6. doi: 10.1016/j.arcped.2009.09.007. Epub 2009 Oct 24.

引用本文的文献

1
Derivation and Validation of D-RISK: An Electronic Health Record-Driven Risk Score to Detect Undiagnosed Dysglycemia in Clinical Practice.D-RISK的推导与验证:一种由电子健康记录驱动的风险评分,用于在临床实践中检测未诊断的血糖异常。
Diabetes Care. 2025 May 1;48(5):703-710. doi: 10.2337/dc24-1624.
2
Development and validation of prediabetes risk score for predicting prediabetes among Indonesian adults in primary care: Cross-sectional diagnostic study.用于预测印度尼西亚初级保健机构成年人间糖尿病前期的糖尿病前期风险评分的开发与验证:横断面诊断研究
Interv Med Appl Sci. 2017 Jun;9(2):76-85. doi: 10.1556/1646.9.2017.2.18.
3
Patient, Provider, and System Factors Associated With Failure to Follow-Up Elevated Glucose Results in Patients Without Diagnosed Diabetes.未确诊糖尿病患者血糖结果升高后随访失败的患者、医护人员及系统因素
Health Serv Res Manag Epidemiol. 2017 Aug 29;4:2333392817721647. doi: 10.1177/2333392817721647. eCollection 2017 Jan-Dec.
4
Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes.采用随机血糖病例发现策略检测未诊断糖尿病的效果
Am J Prev Med. 2017 Jun;52(6):710-716. doi: 10.1016/j.amepre.2017.01.023. Epub 2017 Mar 6.
5
Pre-diagnosis blood glucose and prognosis in women with breast cancer.乳腺癌女性患者的诊断前血糖水平与预后
Cancer Metab. 2016 Apr 6;4:7. doi: 10.1186/s40170-016-0147-7. eCollection 2016.
6
Random blood glucose: a robust risk factor for type 2 diabetes.随机血糖:2型糖尿病的一个可靠风险因素。
J Clin Endocrinol Metab. 2015 Apr;100(4):1503-10. doi: 10.1210/jc.2014-4116. Epub 2015 Feb 4.
7
The effects of a community-based, culturally tailored diabetes prevention intervention for high-risk adults of Mexican descent.一项针对墨西哥裔高危成年人的、基于社区且量身定制的糖尿病预防干预措施的效果。
Diabetes Educ. 2014 Mar-Apr;40(2):202-13. doi: 10.1177/0145721714521020. Epub 2014 Feb 7.
8
Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda.低收入国家高血糖的分布及相关心血管疾病危险因素:乌干达农村一项基于人群的横断面调查
Int J Epidemiol. 2011 Feb;40(1):160-71. doi: 10.1093/ije/dyq156. Epub 2010 Oct 5.

本文引用的文献

1
Risk scores for type 2 diabetes can be applied in some populations but not all.2型糖尿病风险评分可应用于某些人群,但并非所有人群。
Diabetes Care. 2006 Feb;29(2):410-4. doi: 10.2337/diacare.29.02.06.dc05-0945.
2
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.空腹及餐后2小时血糖浓度与死亡率的关系:来自巴尔的摩纵向衰老研究的数据及文献综述
Diabetes Care. 2005 Nov;28(11):2626-32. doi: 10.2337/diacare.28.11.2626.
3
The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England.风险评分作为少数族裔群体未诊断高血糖筛查试验的性能:来自1999年英格兰健康调查的数据。
Diabetes Care. 2004 Jan;27(1):116-22. doi: 10.2337/diacare.27.1.116.
4
Opportunistic screening for diabetes in routine clinical practice.在常规临床实践中对糖尿病进行机会性筛查。
Diabetes Care. 2004 Jan;27(1):9-12. doi: 10.2337/diacare.27.1.9.
5
Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey.利用常见临床信息预测糖耐量受损:来自第三次全国健康与营养检查调查的数据
Diabetes Care. 2003 Jul;26(7):2058-62. doi: 10.2337/diacare.26.7.2058.
6
The diabetes risk score: a practical tool to predict type 2 diabetes risk.糖尿病风险评分:一种预测2型糖尿病风险的实用工具。
Diabetes Care. 2003 Mar;26(3):725-31. doi: 10.2337/diacare.26.3.725.
7
The performance of a risk score in predicting undiagnosed hyperglycemia.
Diabetes Care. 2002 Jun;25(6):984-8. doi: 10.2337/diacare.25.6.984.
8
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.通过生活方式干预或二甲双胍降低2型糖尿病的发病率。
N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.
9
The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.2型糖尿病筛查的成本效益。美国疾病控制与预防中心糖尿病成本效益研究小组
JAMA. 1998 Nov 25;280(20):1757-63.